Skip to main content
. 2017 Jul 17;12(7):e0180768. doi: 10.1371/journal.pone.0180768

Table 2. Incidence (and percentage) of human serum IgM and IgG antibodies binding to pRBCs and pAECs.

Target cells IgM Incidence (%) IgG Incidence (%)
pRBCs Anti-nonGal Anti-nonGal
63/84 (75%) 55/84 (66%)
Anti-nonGal/nonNeuGc Anti-nonGal/nonNeuGc
19/84 (23%) 12/84 (14%)
pAECs Anti-nonGal Anti-nonGal
84/84 (100%) 84/84 (100%)
Anti-nonGal/nonNeuGc Anti-nonGal/nonNeuGc
82/84 (98%) 80/84 (95%)
HHS Vulnerability Disclosure